PMDA drug package insert
ラジカット注30mg
PMDA Prescription drug · 塩野義製薬株式会社 · package insert Oct 1, 2026
Key facts
| Brand names | ラジカット注30mg |
|---|---|
| Nonproprietary names | エダラボン |
| Companies | 製造販売元／塩野義製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | フリーラジカルスカベンジャー |
| Therapeutic category codes | 87119 |
| YJ codes | 1190401A1023 |
| Approval numbers | 21300AMZ00377 |
| Package insert edition | 第6版 |
| Package insert date | Oct 1, 2026 |
| PMDA document key | 340018_1190401A1023_4 |
| PMDA company code | 340018 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: